Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Crane NXT
CXT
$2.88B
| $8.41M | 0.01% |
286,003
-7,845
| -3% | -$222K |
|
1377
Pan American Silver
PAAS
$22.1B
| $8.4M | 0.01% |
633,853
+102,088
| +19% | +$1.43M |
|
|
MSGN
1378
DELISTED
MSG Networks Inc.
MSGN
| $8.37M | 0.01% |
384,618
+251,900
| +190% | +$5.81M |
|
|
WLL
1379
DELISTED
Whiting Petroleum Corporation
WLL
| $8.34M | 0.01% |
4,256
-747
| -15% | -$1.51M |
|
1380
STAAR Surgical
STAA
$1.15B
| $8.33M | 0.01% |
243,699
-250,312
| -51% | -$8.86M |
|
1381
Arcosa
ACA
$7.14B
| $8.33M | 0.01% |
272,683
+232,510
| +579% | +$7.1M |
|
1382
Koppers
KOP
$858M
| $8.33M | 0.01% |
320,541
+218,638
| +215% | +$5.14M |
|
1383
RenaissanceRe
RNR
$13.6B
| $8.32M | 0.01% |
58,017
+47,361
| +444% | +$6.63M |
|
|
MDP
1384
DELISTED
Meredith Corporation
MDP
| $8.29M | 0.01% |
150,042
+1,025
| +0.7% | +$56.9K |
|
|
INST
1385
DELISTED
Instructure, Inc.
INST
| $8.28M | 0.01% |
175,716
-91,023
| -34% | -$3.82M |
|
1386
Landstar System
LSTR
$6.12B
| $8.25M | 0.01% |
75,427
+12,418
| +20% | +$1.31M |
|
1387
CALL
TG Therapeutics
TGTX
$8.55B
| $8.24M | 0.01% |
+1,025,100
| New | +$5.54M |
|
1388
Virgin Galactic
SPCE
$455M
| $8.24M | 0.01% |
40,426
-901
| -2% | -$182K |
|
1389
Acadia Pharmaceuticals
ACAD
$5.23B
| $8.22M | 0.01% |
306,161
-599,255
| -66% | -$14M |
|
1390
CALL
Intuitive Surgical
ISRG
$131B
| $8.22M | 0.01% |
43,200
+13,200
| +44% | +$2.35M |
|
1391
Acuity Brands
AYI
$10.2B
| $8.21M | 0.01% |
68,425
-52,920
| -44% | -$6.58M |
|
|
CRCM
1392
DELISTED
CARE.COM, INC.
CRCM
| $8.21M | 0.01% |
415,611
-785,786
| -65% | -$17.6M |
|
1393
PUT
Capital One
COF
$134B
| $8.21M | 0.01% |
+100,500
| New | +$8.17M |
|
|
CADE
1394
DELISTED
Cadence Bancorporation
CADE
| $8.21M | 0.01% |
442,552
+272,695
| +161% | +$5.18M |
|
1395
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $8.21M | 0.01% |
89,608
+54,179
| +153% | +$4.96M |
|
|
CBPX
1396
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $8.17M | 0.01% |
329,669
+17,495
| +6% | +$460K |
|
1397
Constellium
CSTM
$3.58B
| $8.17M | 0.01% |
1,023,275
-850,976
| -45% | -$7.27M |
|
1398
PUT
Qiagen
QGEN
$8.86B
| $8.14M | 0.01% |
+188,611
| New | +$7.59M |
|
1399
Boise Cascade
BCC
$2.82B
| $8.12M | 0.01% |
303,533
-154,069
| -34% | -$4.15M |
|
1400
PUT
AstraZeneca
AZN
$264B
| $8.09M | 0.01% |
+100,000
| New | +$7.88M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.